Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Solid Cancers × Immune Checkpoint Inhibitors × Clear all

Phase

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 5 Stomach Neoplasms 4 Carcinoma, Non-Small-Cell Lung 3 Triple Negative Breast Neoplasms 2 Gastric / Gastroesophageal Junction Adenocarcinoma 2 Esophageal Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Spinocerebellar Degenerations 1 Solid Tumors 1 Solid Cancers 1 Small Cell Lung Carcinoma 1 Recurrence 1 Pathologic Complete Response 1 Pancreatic Cancer Metastatic 1 Oropharyngeal Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Cancinoma (NPC) 1 Mouth Neoplasms 1 Melanoma 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell 1 Lung Neoplasms 1 Locally Advanced Rectal Cancer 1 Hypersensitivity 1 Esophageal Squamous Cell Carcinoma 1 EBV-associated Tumors 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Renal Cell 1

Interventions

Immune Checkpoint Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07427186 2026-02-25

MINER2

Institut Claudius Regaud

Phase NA Not yet recruiting

Solid Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡